Skip to content

Free cash flow at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$848.3M+4.0%
Opko Health logo
Opko HealthOPK
-$21.14M+44.0%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$44.87M+22.5%
ALN
Alnylam PharmaceuticalsALNY
$48.67M+138%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$117.43M+21.5%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
-$40.95M-39.5%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%

Valuation

See full
Market cap$1.07B+31.9%
Enterprise value$1.07B+26.9%
P/S13.5×-10.1×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Calculated from MeiraGTx Holdings plc’s reported figures.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's free cash flow?
MeiraGTx Holdings plc (MGTX) reported free cash flow of $15.8M in Q1 2026.
How has MeiraGTx Holdings plc's free cash flow changed year-over-year?
MeiraGTx Holdings plc's free cash flow increased by 141.0% year-over-year, from -$38.54M to $15.8M.
What is the long-term trend for MeiraGTx Holdings plc's free cash flow?
Over 3 years (2021 to 2024), MeiraGTx Holdings plc's free cash flow has grown at a 24.4% compound annual growth rate (CAGR), from -$56.88M to -$109.45M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.